412 related articles for article (PubMed ID: 9307275)
21. PTEN mutations in uterine sarcomas.
Amant F; de la Rey M; Dorfling CM; van der Walt L; Dreyer G; Dreyer L; Vergote I; Lindeque BG; Van Rensburg EJ
Gynecol Oncol; 2002 Apr; 85(1):165-9. PubMed ID: 11925138
[TBL] [Abstract][Full Text] [Related]
22. The coexistence of ERBB2, INT2, and CMYC oncogene amplifications and PTEN gene mutations in endometrial carcinoma.
Konopka B; Janiec-Jankowska A; Paszko Z; Goluda M
J Cancer Res Clin Oncol; 2004 Feb; 130(2):114-21. PubMed ID: 14663583
[TBL] [Abstract][Full Text] [Related]
23. Somatic deletion mapping on chromosome 10 and sequence analysis of PTEN/MMAC1 point to the 10q25-26 region as the primary target in low-grade and high-grade gliomas.
Maier D; Zhang Z; Taylor E; Hamou MF; Gratzl O; Van Meir EG; Scott RJ; Merlo A
Oncogene; 1998 Jun; 16(25):3331-5. PubMed ID: 9681833
[TBL] [Abstract][Full Text] [Related]
24. Mutation of the PTEN tumor suppressor gene is not a feature of ovarian cancers.
Maxwell GL; Risinger JI; Tong B; Shaw H; Barrett JC; Berchuck A; Futreal PA
Gynecol Oncol; 1998 Jul; 70(1):13-6. PubMed ID: 9698466
[TBL] [Abstract][Full Text] [Related]
25. Mutational analysis of the PTEN gene in endometrial carcinoma and hyperplasia.
Sun H; Enomoto T; Fujita M; Wada H; Yoshino K; Ozaki K; Nakamura T; Murata Y
Am J Clin Pathol; 2001 Jan; 115(1):32-8. PubMed ID: 11190805
[TBL] [Abstract][Full Text] [Related]
26. DCC genetic alterations and expression in endometrial carcinoma.
Ronnett BM; Burks RT; Cho KR; Hedrick L
Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725
[TBL] [Abstract][Full Text] [Related]
27. MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Teng DH; Hu R; Lin H; Davis T; Iliev D; Frye C; Swedlund B; Hansen KL; Vinson VL; Gumpper KL; Ellis L; El-Naggar A; Frazier M; Jasser S; Langford LA; Lee J; Mills GB; Pershouse MA; Pollack RE; Tornos C; Troncoso P; Yung WK; Fujii G; Berson A; Steck PA
Cancer Res; 1997 Dec; 57(23):5221-5. PubMed ID: 9393738
[TBL] [Abstract][Full Text] [Related]
28. PTEN mutation in endometrial cancers is associated with favorable clinical and pathologic characteristics.
Risinger JI; Hayes K; Maxwell GL; Carney ME; Dodge RK; Barrett JC; Berchuck A
Clin Cancer Res; 1998 Dec; 4(12):3005-10. PubMed ID: 9865913
[TBL] [Abstract][Full Text] [Related]
29. Molecular pathology of endometrial hyperplasia and carcinoma.
Matias-Guiu X; Catasus L; Bussaglia E; Lagarda H; Garcia A; Pons C; Muñoz J; Argüelles R; Machin P; Prat J
Hum Pathol; 2001 Jun; 32(6):569-77. PubMed ID: 11431710
[TBL] [Abstract][Full Text] [Related]
30. PTEN / MMAC1 mutation and frequent loss of heterozygosity identified in chromosome 10q in a subset of hepatocellular carcinomas.
Fujiwara Y; Hoon DS; Yamada T; Umeshita K; Gotoh M; Sakon M; Nishisho I; Monden M
Jpn J Cancer Res; 2000 Mar; 91(3):287-92. PubMed ID: 10760687
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.
Feilotter HE; Coulon V; McVeigh JL; Boag AH; Dorion-Bonnet F; Duboué B; Latham WC; Eng C; Mulligan LM; Longy M
Br J Cancer; 1999 Feb; 79(5-6):718-23. PubMed ID: 10070859
[TBL] [Abstract][Full Text] [Related]
32. PTEN/MMAC1/TEP1 involvement in primary prostate cancers.
Pesche S; Latil A; Muzeau F; Cussenot O; Fournier G; Longy M; Eng C; Lidereau R
Oncogene; 1998 Jun; 16(22):2879-83. PubMed ID: 9671408
[TBL] [Abstract][Full Text] [Related]
33. Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues.
Suzuki H; Freije D; Nusskern DR; Okami K; Cairns P; Sidransky D; Isaacs WB; Bova GS
Cancer Res; 1998 Jan; 58(2):204-9. PubMed ID: 9443392
[TBL] [Abstract][Full Text] [Related]
34. Alteration of PTEN expression in endometrial carcinoma is associated with down-regulation of cyclin-dependent kinase inhibitor, p27.
An HJ; Lee YH; Cho NH; Shim JY; Kim JY; Lee C; Kim SJ
Histopathology; 2002 Nov; 41(5):437-45. PubMed ID: 12405911
[TBL] [Abstract][Full Text] [Related]
35. Abnormal structure and expression of PTEN/MMAC1 gene in human uterine cancers.
Yaginuma Y; Yamashita T; Ishiya T; Morizaki A; Katoh Y; Takahashi T; Hayashi H; Ishikawa M
Mol Carcinog; 2000 Feb; 27(2):110-6. PubMed ID: 10657903
[TBL] [Abstract][Full Text] [Related]
36. Association of PTEN mutation with HPV-negative adenocarcinoma of the uterine cervix.
Minaguchi T; Yoshikawa H; Nakagawa S; Yasugi T; Yano T; Iwase H; Mizutani K; Shiromizu K; Ohmi K; Watanabe Y; Noda K; Nishiu M; Nakamura Y; Taketani Y
Cancer Lett; 2004 Jul; 210(1):57-62. PubMed ID: 15172121
[TBL] [Abstract][Full Text] [Related]
37. Exclusion of a major role for the PTEN tumour-suppressor gene in breast carcinomas.
Freihoff D; Kempe A; Beste B; Wappenschmidt B; Kreyer E; Hayashi Y; Meindl A; Krebs D; Wiestler OD; von Deimling A; Schmutzler RK
Br J Cancer; 1999 Feb; 79(5-6):754-8. PubMed ID: 10070865
[TBL] [Abstract][Full Text] [Related]
38. PTEN methylation is associated with advanced stage and microsatellite instability in endometrial carcinoma.
Salvesen HB; MacDonald N; Ryan A; Jacobs IJ; Lynch ED; Akslen LA; Das S
Int J Cancer; 2001 Jan; 91(1):22-6. PubMed ID: 11149415
[TBL] [Abstract][Full Text] [Related]
39. Genetics of synchronous uterine and ovarian endometrioid carcinoma: combined analyses of loss of heterozygosity, PTEN mutation, and microsatellite instability.
Fujii H; Matsumoto T; Yoshida M; Furugen Y; Takagaki T; Iwabuchi K; Nakata Y; Takagi Y; Moriya T; Ohtsuji N; Ohtsuji M; Hirose S; Shirai T
Hum Pathol; 2002 Apr; 33(4):421-8. PubMed ID: 12055677
[TBL] [Abstract][Full Text] [Related]
40. Absence of PTEN repeat tract mutation in endometrial cancers with microsatellite instability.
Cohn DE; Basil JB; Venegoni AR; Mutch DG; Rader JS; Herzog TJ; Gersell DJ; Goodfellow PJ
Gynecol Oncol; 2000 Oct; 79(1):101-6. PubMed ID: 11006040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
